Yazitin Injection 2 ml.

Rusan Pharma Ltd offers a wide range of creams/ gels & ointments which includes valoderm g cream 30 gm. Package size/ Form: N.1 tube. Contact us for more information.

Rusan Pharma Ltd offers a wide range of tablets which includes verapamil 120 mg tablets. Package size/ Form: N.28 tablet. Contact us for more information.

Rusan Pharma Ltd offers a wide range of tablets which includes verapamil 40 mg tablets. Package size/ Form: N.84 tablet. Contact us for more information.

Rusan Pharma Ltd offers a wide range of tablets which includes verapamil 80 mg tablets. Package size/ Form: N.84 tablet. Contact us for more information.

Rusan Pharma Ltd offers a wide range of small volume parenterals which includes vescue injection 2 ml. Package size/ Form: 2 ml injection. Contact us for more information.

Rusan Pharma Ltd offers a product which includes vulcin kit. Package size: N.1. Contact us for more information.

Rusan Pharma Ltd offers a wide range of tablets which includes yazitin-150 tablet. Package size/ Form: N.100 tablet. Contact us for more information.

Rusan Pharma Ltd offers a wide range of tablets which includes yazitin-300 tablet. Package size/ Form: N.100 tablet. Contact us for more information.

1.Better Patient Compliance 2.Rigorousely Tested by AIIMS (Delhi)
 3.Faster Onset Of Action

Addnok-N® is an opioid medication known for its ceiling effect, which enhances safety in administration for patients. The product is available in ...

1. Reduces Cravings For Alcohol      2. Rapid Detoxification & quick onset of action  
 3.  Reduces risk of Relapse      
4. Effective in both opioid & alcohol de- addiction 

Rusan Pharma Ltd offers a wide range of tablets which includes bioran tablet. Package size/ Form: N.100 tablet. Contact us for more information.

1. Opioid adverse effects (opioid neurotoxicity) 2.  Opioid induced tolerance and hyperalgesia  3. Treatment of moderate to severe pain not responsive to non-narcotic analgesics 

RUSAN PHARMA PRIVATE LIMITED, an Indian pharmaceutical company specializing in addiction treatment and pain management, announced that its Active Pharmaceutical Ingredient (API) facility in Ankleshwar, Gujarat, received Good Manufacturing Practice (GMP) approval from the USFDA on May 29, 2024, following a rigorous inspection. This approval marks a significant milestone, enabling Rusan to expand into the US API market, particularly for niche APIs like Eflornithine and Nalmefene, while planning to add more APIs to its portfolio. Rusan Pharma’s Managing Director, Dr. Kunal Saxena, emphasized the company’s commitment to quality and global expansion. The USFDA approval complements Rusan's existing GMP certifications from Health Canada, the EU, and Brazil’s ANVISA, and aligns with the company’s vision to be a leader in addiction treatment and pain management. 

Commercials APIs  & APIs Under Development